Trial intelligence / Profile preview

Phase III trial of Jianwei Qutong Pills in chronic non-atrophic gastritis

CTR20233804Phase 3Active

Sponsor
Fangsheng Pharmaceutical
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Jianwei Qutong Wan in chronic non-atrophic gastritis, sponsored by Fangsheng Pharmaceutical. Started May 2024; status: active.

02

Drugs

Jianwei Qutong Wan
03

Conditions

chronic non-atrophic gastritis

Beyond the preview

Go deeper on CTR20233804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20233804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call